Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy, European Journal of Cancer, September 2019, Elsevier,
DOI: 10.1016/j.ejca.2019.05.031.
You can read the full text:
Contributors
The following have contributed to this page
